Sage Journals: Discover world-class research

Abstract

Neurovascular and neurometabolic coupling help the brain to maintain an appropriate energy flow to the neural tissue under conditions of increased neuronal activity. Both coupling phenomena provide us, in addition, with two macroscopically measurable parameters, blood flow and intermediate metabolite fluxes, that are used to dynamically image the functioning brain. The main energy substrate for the brain is glucose, which is metabolized by glycolysis and oxidative breakdown in both astrocytes and neurons. Neuronal activation triggers increased glucose consumption and glucose demand, with new glucose being brought in by stimulated blood flow and glucose transport over the blood-brain barrier. Glucose is shuttled over the barrier by the GLUT-1 transporter, which, like all transporter proteins, has a ceiling above which no further stimulation of the transport is possible. Blood-brain barrier glucose transport is generally accepted as a nonrate-limiting step but to prevent it from becoming rate-limiting under conditions of neuronal activation, it might be necessary for the transport parameters to be adapted to the increased glucose demand. It is proposed that the blood-brain barrier glucose transport parameters are dynamically adapted to the increased glucose needs of the neural tissue after activation according to a neurobarrier coupling scheme. This review presents neurobarrier coupling within the current knowledge on neurovascular and neurometabolic coupling, and considers arguments and evidence in support of this hypothesis.

Keywords

blood vessels cerebral blood flow energy metabolism functional hyperemia glucose metabolism neurovascular unit

Introduction

The brain consists of neurons and glial cells that mutually influence each other and collaborate to keep the brain functional and to perform a spectrum of impressively complex tasks. In addition to the neurons and glial cells, there is a third cell partner present, namely, the vascular cells. Blood vessels are linked to neuronal functioning through the process of neurovascular coupling, that is, the coupling of vessel diameter and thus blood flow, to neuronal activity (Harder et al, 1998; Iadecola, 1993; Kuschinsky, 1997; Lou et al, 1987; Villringer and Dirnagl, 1995; Wahl and Schilling, 1993). Neurovascular coupling or functional hyperemia matches the supply of blood and nutrients to the local needs of the brain cells and brings about an increased blood flow after local neuronal activation. Through this process, vascular cells are functionally linked to the neural tissue, making them essential members of the diverse family of brain cells that together constitute the neurovascular unit. This is elegantly illustrated by the recent work of Zonta et al (2003), who demonstrated in acute brain slices from rat cortex that neuronal activation causes vasodilation through a communication chain passing from neurons over astrocytes to the vascular cells. Neuronal activity is determined by the electric and synaptic activity, that is, the rate of action potential firing, the release of neurotransmitter vesicles from the presynaptic ending, and the subsequent postsynaptic chemical and electrical responses. Most of the energy needs of the neural tissue derive from restoration of transmembrane ion gradients that are temporarily disturbed by action potentials and postsynaptic currents (Attwell and Iadecola, 2002). Glucose is under normal circumstances the only useful energy substrate for the brain, being degraded by glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation (Chih and Roberts Jr., 2003). As expected from neurovascular coupling, regional glucose use and consumption in the brain is strongly correlated with the local blood flow (Bryan et al, 1983; Clarke and Sokoloff, 1999; Ginsberg et al, 1986; Hawkins et al, 1985; Sokoloff, 1977), thereby linking neuronal activity, metabolic rate, and blood flow. Work from the group of Magistretti and others has demonstrated that neuronal activity and glucose metabolism are more than just linked and are effectively tied together (Magistretti et al, 1999). According to their hypothesis, which has been critically reviewed recently (Chih and Roberts Jr. 2003), glucose metabolism is compartmentalized in the brain under conditions of activation, with glycolytic breakdown localized in the astrocytes, and TCA processing and oxidative breakdown taking place in the neurons (Pellerin et al, 1998); recent data seem to confirm such a scheme (Kasischke et al, 2004). Glutamate released from glutamatergic synapses is taken up by the astrocytes in cotransport with sodium, thereby increasing intracellular sodium and stimulating the sodium-potassium pump (Pellerin and Magistretti, 1997). This increases the astrocytic ATP consumption and drives glycolysis to back up the cellular ATP content. The product of glycolysis in astrocytes is lactate, a monocarboxylic acid that is assumed to be shuttled to the neurons for further breakdown in the TCA cycle (Bittar et al, 1996; Schurr et al, 1999). This signaling cascade links neuronal glutamate release and astrocytic glucose metabolism in a stoichiometric manner (Magistretti et al, 1999), thereby securing narrow metabolic coupling between neurons and astrocytes, which is called neurometabolic coupling (Magistretti and Pellerin, 1999; other aspects of neuron-astrocyte metabolic interactions are discussed in Deitmer, 2001; Fillenz et al, 1999; Hertz et al, 2000; Tsacopoulos and Magistretti, 1996). In the following discussion, we present a third aspect of coupling that may act in concert with neurovascular and neurometabolic coupling to help furnish an adequate glucose supply to the neural tissue on activation. It concerns the coupling of neuronal activity to the activity of the glucose transporters that shuttle glucose over the blood-brain barrier, a coupling phenomenon we propose to call neurobarrier coupling (Figures 1 and 2).

Blood-Brain Barrier Glucose Transport

The functional players of neurovascular and neurometabolic coupling are neuronal activity, metabolic rate in astrocytes and neurons, and blood flow. In addition to these three, a fourth parameter, which is the transport of glucose from the blood to the brain, needs further consideration. Brain glucose transport involves the breaching of two barriers, including the blood-brain barrier formed by the capillary endothelial cells, which are effectively connected together by tight junctions, and the barrier formed by the plasma membranes of neurons and astrocytes to which glucose must be delivered. Glucose transport over the endothelial blood-brain barrier is mediated by facilitated diffusion via the GLUT-1 transporter, which is located at very high density in both luminal and abluminal plasmamembranes of the endothelial cells (Pardridge, 1991). Transport of glucose into the astrocytes occurs through the same transporter that is present in these cells (although at far lower density) under a less glycosylated form with lower molecular weight (45 kDa) as compared with the endothelial transporter (55 kDa; Dwyer et al, 2002; Vannucci et al, 1997). Neurons consume, in addition to astrocytic lactate, glucose that is transported into these cells through the GLUT-3 transporter (Leino et al, 1997). The relative contribution of glucose and lactate as neuronal energy substrates is currently not fully established (Chih and Roberts Jr., 2003), but neuronal glycolysis (and glucose uptake) is, like astrocytic glycolysis, also tightly coupled to neuronal activity by means of activation of the glycolytic enzymes hexokinase, phosphofructokinase, and pyruvate kinase when the cellular ATP concentration is lowered as a consequence of increased neuronal activity (Magistretti, 2003) (Figure 3).

Figure 1

Neuronal activity triggers various responses that act together to adapt the delivery of energy substrate to the local neuronal needs. Neurovascular coupling involves the dilation of blood vessels to increase the local blood flow, while neurometabolic coupling denotes the stimulation of energy metabolism to keep up with cellular ATP consumption. We propose that neuronal activity brings about changes at the level of the blood-brain barrier (BBB), establishing neurobarrier coupling that acts to increase the transport of energy substrate, mainly glucose, over the barrier.

Figure 2

Neurovascular coupling acts to relax smooth muscle cells (SMC) of arterioles to increase the local cerebral blood flow (CBF). Neurometabolic coupling involves interactions (signals and transports) between neurons (N) and astrocytes (A) that trigger the glycolytic breakdown of glucose. The targets of neurobarrier coupling are the endothelial cells (EC) that make up the blood-brain barrier (BBB). Astrocytes form a relay station between neurons and vascular cells and contribute as an intermediate signaling step in neurovascular coupling. Astrocytes are in very close contact with the majority of blood-brain barrier endothelial cells, opening up the possibility that astrocyte-to-endothelial cell communication is involved in neurobarrier coupling.

Figure 3

Neurometabolic coupling pathways. Glucose (G) enters the brain interstitium via the 55 kDa GLUT-1 transporter in the luminal and abluminal plasma membranes of blood-brain barrier endothelial cells (EC). Neurons (N) take up glucose via GLUT-3 transporters, convert it to pyruvate (P) via glycolysis (yielding 2 ATP per molecule of glucose) and metabolize it further via the tricarboxylic acid cycle and oxidative phosphorylation (yielding 17 ATP per molecule of pyruvate). On brain activation, the ATP concentration in the neurons ([ATP]_i) decreases, thereby releasing the negative feedback of ATP on the glycolytic enzymes hexokinase, phosphofructokinase, and pyruvate kinase, and stimulating glycolysis. Brain activation is associated with increased activity at glutamatergic synapses and the released glutamate is taken up by the astrocytes (A) in cotransport with sodium (via GLT-1 and GLAST transporters). The intracellular sodium load in astrocytes is removed via the Na/K pump that consumes ATP and thereby stimulates astrocytic glycolysis. Lactate (L), the endproduct of glycolysis in astrocytes (by conversion from pyruvate via LDH₅), leaves the cells via MCT₁ mono-carboxylate transporters and is taken up by the neurons via MCT₁ and MCT₂ (astrocyte-neuron lactate shuttle hypothesis). In the neurons, lactate is converted to pyruvate via LDH₁ and is further degraded oxidatively. Glutamate is recycled via the glutamate-glutamine cycle acting between astrocytes and neurons (not shown). Glucose is delivered to the astrocytes via the 45 kDa GLUT-1 transporter in the plasma membranes of astrocytic end-feet. Astrocytes also contain a small glycogen stock (not shown) that can be mobilized on brain activation and subsequently refilled with blood glucose. References are given in the text. The stoichiometries of glucose breakdown have been omitted for simplicity.

An important question concerning brain glucose transport and metabolism is the localization of the rate-limiting step. From the two barriers referred to, the barrier located at neuronal/astrocytic plasma membranes is the most permeable one because there appears to be no glucose concentration difference between the intra- and extracellular brain compartments (Gjedde and Diemer, 1983; Gruetter et al, 1996; Pfeuffer et al, 2000; Silver and Erecinska, 1994). The blood-brain barrier is less permeable because it separates two spaces with different glucose concentrations: approximately 5mmol/L in the blood plasma at normoglycemia and approximately 1 mmol/L in the brain extracellular space (range 0.35 to 2.6 mmol/L depending on the brain region where the measurement was done, the measurement technique, and the state of wakefulness, as illustrated in Table 1).

Table 1

Brain extracellular glucose concentrations

Glucose concentration (mmol/L)	Region, species and conditions	Measurement method	Reference

2.60	Hippocampus, rat, anesthetized	Glucose-sensitive micro-electrodes	Hu and Wilson (1997)
2.40	Cingulate area, rat, anesthetized	Glucose-sensitive micro-electrodes	Silver and Erecinska (1994)
1.00	Occipito-parietal, human, awake	¹³C NMR spectroscopy	Gruetter et al (1992)
1.00–1.24	Hippocampus, rat, anesthetized	Microdialysis	McNay and Gold (1999)
0.71	Striatum, rat, awake and freely moving	Microdialysis	McNay et al (2001)
0.47	Striatum, rat, awake and freely moving	Microdialysis	Fellows et al (1992)
0.35	Striatum, rat, awake and freely moving	Microdialysis	Fray et al (1997)
0.35	Striatum, rat, awake and freely moving	Glucose-sensitive micro-electrodes	Lowry et al (1998)

Despite its lower glucose permeability, the transport of glucose over the blood-brain barrier is generally assumed to be not rate-limiting for glucose metabolism, because if it was rate-limiting then glucose delivery would become precarious in view of fluctuations in plasma glucose (Davson and Segal, 1996), and brain glucose concentrations would approach zero, which is not observed (Lund-Andersen, 1979). Further arguments are that the 1 mmol/L brain glucose concentration is largely above the K_m of the hexokinase (50 μmol/L, Lund-Andersen, 1979), the first enzymatic step in glycolytic glucose degradation, and that the blood-brain barrier glucose transport rate (symbolized by T_G) is approximately 50% above the metabolic rate of glucose consumption (symbolized by CMR_G) under basal conditions (de Graaf et al, 2001). The first rate-limiting step thus appears to be glucose phosphorylation by the hexokinase (Furler et al, 1991; Robinson and Rapoport, 1986). Blood-brain glucose transport can however become rate-limiting when the blood glucose concentration decreases below 3 mmol/L (hypoglycemia) (Gruetter et al, 1992), in which case the brain glucose concentration will start to decrease (Blomqvist et al, 1998; Choi et al, 2001). In addition, the transport can become rate-limiting as a result of compromised blood-brain barrier transport in Alzheimer's disease (Kalaria and Harik, 1989), after an epileptic insult with associated increased metabolic consumption or in the case of an inherited deficiency in GLUT-1 transporter (De Vivo et al, 1991; Klepper et al, 1999; Siesjo, 1978; Vannucci et al, 1998a; Vannucci et al, 1997).

Adaptation and Regulation of Blood-Brain Barrier Glucose Transport

Transport or reaction steps that are not rate-limiting are, in general, not considered as important regulation points within a transport or reaction cascade. Because blood-brain barrier glucose transport is not rate-limiting, it follows that this transport is not involved in regulating brain glucose metabolism (Gruetter et al, 1996). This does not however exclude the fact that blood-brain barrier glucose transport is adapted under certain conditions. Sustained or repeated decreases or increases of the plasma glucose concentration, as occur in poorly controlled diabetes, are known to upregulate or downregulate, respectively, blood-brain barrier glucose transport, with the aim of providing a constant glucose supply to the brain (Christensen et al, 1981; Gjedde and Crone, 1981; Hasselbalch et al, 2001b, 1995; McCall et al, 1982; Mooradian and Morin, 1991; Pardridge et al, 1990; Pelligrino et al, 1990). In addition, glucose transport over the blood-brain barrier changes in function during development (Bauer et al, 1995; Devaskar et al, 1991) and displays regional variability, with the transport rate being in line with the local metabolic demands (de Graaf et al, 2001; Hawkins et al, 1983) and blood flow (Gjedde and Diemer, 1985; Schrock and Kuschinsky, 1988; Sokoloff, 1978). These examples thus illustrate long-term glucose transport regulation controlled by development, plasma glucose levels, local metabolic needs, and bloodflow.

Glucose Transport and Consumption

In most models currently used, blood-brain barrier glucose transport is described by a Michaelis-Menten function. Determined through various methods, both in rodents and humans, the K_m value of the Michaelis-Menten relation, which in the context of blood-brain barrier transport is symbolized by K_t, is in the range of 5 to 10 mmol/L when the data fit is performed using a standard ‘symmetric’ Michaelis-Menten-based model (Gruetter et al, 1996, Gruetter et al, 1998; Lund-Andersen, 1979) and in the order of 1 to 2 mmol/L when modeling is performed with the ‘reversible’ model that includes a product inhibition effect at the brain side (Choi et al, 2001; Cunningham, 1986; Cunningham et al, 1986; Gjedde, 1992; Gruetter et al, 1998; Mason et al, 1992; Rothman, 2001). The V_max, symbolized by T_max for barrier transport, is in the order of 1 μmol/g per minute (Gjedde, 1992; Gruetter et al, 1996) with slightly higher values (1 to 1.5 range) obtained with the standard model (Betz and Iannotti, 1983; Pardridge, 1983) and lower values (0.65) with the reversible model (de Graaf et al, 2001; Gruetter et al, 1998). The lower K_t estimates of 1 to 2 mmol/L are close to the K_m values for the GLUT-1 transporter (0.5 to 2 mmol/L; Carruthers, 1990) and are therefore considered as the more precise estimate (Gruetter et al, 1998). With a K_t of 1.5 mmol/L and a plasma glucose concentration of 5 mmol/L, the blood-brain barrier glucose transport is calculated to attain 77% of its maximal value with the most simple Michaelis-Menten formulation:

T_{G} = T_{max} (\frac{1}{1 + (K_{t} / {[G]}_{lum})})

(1)

[G]_lum in this equation denotes the glucose concentration at the luminal (blood) side of the barrier. This yields a resting (basal) T_G value of approximately 0.77 μmol per g wet weight per minute. The calculation can be repeated with a more correct transport equation in which abluminal glucose ([G]_ablum) is not assumed to be zero (Aubert and Costalat, 2002; Friedman, 1986; Lund-Andersen, 1979):

T_{G} = T_{max} (\frac{1}{1 + (K_{t} / {[G]}_{lum})} - \frac{1}{1 + (K_{t} / {[G]}_{ablum})})

(2)

Substitution of the relevant values ([G]_ablum = 1 mmol/L; K_t and [G]_lum as in the previous calculation) yields a transport of 37% of T_max, that is, 0.37 μmol/g per minute. These calculated T_G values should be contrasted to the CMR_G values, which are in the 0.25 to 0.35 μmol/g per minute range for both rodents and humans (cortex or whole brain under basal conditions; Clarke and Sokoloff, 1999; de Graaf et al, 2001; Gruetter et al, 1996; Hasselbalch et al, 2001a; Magistretti, 2003; Ueki et al, 1988). A comparison of the T_G and CMR_G values indicates that glucose delivery is just enough to keep up with basal glucose consumption (T_G/CMR_G¹ ≈1), with the most correct calculation based on equation (2), and is about twice the basal glucose consumption (100% above CMR_G) when calculated with equation (1). de Graaf et al (2001) have reported a value of 50% above basal CMR_G. Physiological levels of brain activation, for example, as triggered in humans by exposure to visual stimuli, bring about a CMR_G increase in the range of 23% to 51% above baseline (Fox et al, 1988; Shulman and Rothman, 1998), and much larger increases are observed after direct electrical stimulation of the rat skin (Hyder et al, 1996). We conclude from these considerations that blood-brain glucose transport is not rate-limiting under basal conditions but that it may become rate-limiting in brain regions that experience activation.

Glucose Transport and Neurovascular Coupling

Neurovascular coupling is designed to adapt the glucose and oxygen delivery to the increased metabolic needs after brain activation (Magistretti, 2003). The relation between blood flow and substrate delivery is, however, still a matter of debate and this is true for both glucose and oxygen (Barinaga, 1997; Buxton and Frank, 1997; Mintun et al, 2001; Paulson, 2002; Vafaee and Gjedde, 2000). The cerebral blood flow (CBF) is in the order of 0.57 ml/g per minute in the human gray matter under basal conditions (Clarke and Sokoloff, 1999), bringing 2.85 μmol/g per minute glucose to the brain vessel lumen (5 mmol/L blood glucose). At a CMR_G of 0.30 μmol/g per minute, this yields a glucose extraction ratio of approximately 10% (Dirnagl, 1997; Madsen et al, 1995; Paulson, 2002). This contrasts with the much higher extraction ratio of 50% to 70% for oxygen (Dirnagl, 1997; Paulson, 2002). Glucose delivery to the neural tissue can theoretically be elevated by solely increasing the extraction ratio without any change in CBF, but for oxygen there is less extraction reserve and the CBF increase is needed (Paulson, 2002). On brain activation, the CBF increases in proportion to the CMR_G, for example, up to 50% above baseline as reported by Fox et al (1988). An increased vascular glucose supply does not, however, automatically result in an increased delivery to the neural tissue: first, because an increased supply is, in view of the low extraction ratio, hardly expected to affect the local luminal glucose concentration and thus the driving force for glucose to enter the brain, and second, because the barrier transport may be close to becoming rate-limiting. There are theoretically three possibilities to modulate the movement of glucose over the barrier: changing the intrinsic properties of the GLUT-1 transporter by modifying its V_max or K_t, changing the number of GLUT-1 carriers available in the barrier membrane for glucose transport, or changing the driving force for glucose movement over the barrier (Figure 4). The number of functional and accessible GLUT-1 carriers in the barrier membrane can be increased by inserting new transporter protein or by increasing the number of perfused capillaries in response to increased blood flow (Davson and Segal, 1996). Both result in an increased T_max of transbarrier glucose transport because individual carrier proteins act in parallel to sum their V_max.

Figure 4

Glucose transport across the blood-brain barrier (BBB) can, in principle, be stimulated by increasing the glucose concentration gradient (Δ[G]; [G]_lum is the luminal and [G]_ablum the abluminal glucose concentration) over the barrier, thereby stimulating the driving force for glucose movement, by increasing the intrinsic activity of the GLUT-1 transporter through changes in V_max or K_t, or by increasing the number of GLUT-1 carriers available for glucose transport thereby affecting T_max. The number of functionally available GLUT-1 carriers in the barrier membrane can be increased either by inserting new transporter protein or by increasing the capillary surface area available for facilitated glucose entry.

The capillaries in the brain cortex all appear to receive at least some perfusion under resting conditions, making capillary recruitment (as observed in muscle) an unlikely option in the brain (Gobel et al, 1989; Kuschinsky and Paulson, 1992; Villringer et al, 1994). It is now accepted that neuronal activation triggers a transition of low-flow capillaries to high-flow capillaries, thereby causing a more homogeneous distribution in the flow pattern of the capillary bed (Kleinfeld et al, 1998; Vogel and Kuschinsky, 1996), a condition that has been described as functional recruitment (Akgoren and Lauritzen, 1999; Kuschinsky and Paulson, 1992; Paulson, 2002). Currently, there is no quantitative data available to estimate the impact of functional recruitment on the magnitude of the glucose transport over the barrier.

Glucose transport across the blood-brain barrier is generally interpreted in terms of the permeability-surface product (Davson and Segal, 1996) whereby the transport is modulated either by changes in the permeability or by changes in the capillary surface area available for facilitated glucose movement. Permeability² changes are the consequence of changes in the T_max, V_max, or K_t parameters whereas surface area changes are related to functional recruitment at the level of capillaries. The third possibility to affect blood-brain barrier glucose transport relates to the driving force and thus the glucose concentration gradient across the barrier. Glucose concentrations in the brain interstitium are indeed reported to decrease over 10% to 34% in response to activation (Chen et al (1993), Fellows et al (1992), Fray et al (1997), Hu and Wilson (1997), McNay et al (2000), McNay et al (2001), Merboldt et al (1992) and Silver and Erecinska (1994); Lowry et al (1998) reported a more extreme decrease over 52% with veratridine), thereby increasing the transbarrier concentration difference and thus the driving force for glucose entry into the brain interstitium. Substitution of a [G]_ablum value of 0.8 mmol/L (corresponding to an average 20% decrease) in equation (2) increases T_G from 0.37 (at 1 mmol/L) to approximately 0.42 μmol/g per minute, giving an estimated increase of approximately 14% above baseline. This effect is effectively a law of mass action effect whereby an increased glucose sink (metabolic degradation) stimulates the movement of the molecule over the barrier (Figure 3). We retain from these considerations that blood-brain barrier glucose transport can be affected at several levels, of which neurovascular coupling is only one of the possible adaptations that may be involved during brain activation.

Defining the Field for Neurobarrier Coupling

Neurobarrier coupling denotes adaptations in the properties of glucose transport across the blood-brain barrier after brain activation and thus implies changes that are not related to neurovascular coupling. In principle, neurobarrier coupling includes changes in T_max due to increased GLUT-1 incorporation or increased V_max, and alterations in K_t. Adjustments at the level of functional recruitment belong, in contrast, to the domain of neurovascular coupling. Changes in the driving force for glucose movement over the barrier could in principle be incorporated under the term neurobarrier coupling, but because these changes are the direct result of increased metabolism and glucose shifts obeying the law of mass action, we suggest the sorting of this aspect under neurometabolic coupling (Table 2). The time scale of neurobarrier coupling is expected to be in the order of the time scale for neurovascular coupling, that is, in the order of sec after activation (Malonek et al, 1997). However, because there is a limited glycogen stock available in the astrocytes (estimates of the size of this stock can be found in Brown et al, 2004; Gruetter, 2003), the time course may be somewhat extended if the increased glucose transport is used to back up the glycogen stores that have been mobilized in response to increased metabolic demand (Fillenz et al, 1999; Shulman et al, 2001; Swanson, 1992; Swanson et al, 1992). Evidence for an increased GLUT-1 activity on activation has recently become available from the work of Cornford et al (2000), who demonstrated that seizure induction in rats triggers an acute increase, within 3 min, of the T_max of blood-brain barrier glucose transport in the forebrain cortex. This effect was not related to an increased capillary surface area for facilitated glucose transport (based on measurements of the insulin distribution volume) and is thus probably the result of either an increase in the Michaelis-Menten parameters of the GLUT-1 protein or a stimulated GLUT-1 incorporation into the barrier membrane. Earlier studies from Cremer et al (1983) had already demonstrated increased T_max values with seizures, but the time course of these changes was not investigated. A study of Gronlund et al (1996) demonstrated increased GLUT-1 expression in response to chronic seizures that peaked after a delay of 3 days; these authors also described increased expression of the GLUT-3 transporter that peaked after 8 hours. By contrast, the work of Cornford et al (2000) demonstrates acute adaptations within min and is suggestive of the involvement of a signal acting at this time scale. The Cornford et al (2000) study is thus an example of neurobarrier coupling, although that brain activation was brought about by a pathological stimulus. Further investigations will be needed to determine the involvement of neurobarrier coupling under physiological levels of brain activation.

Table 2

Neurobarrier coupling in relation to neurovascular and neurometabolic coupling

Coupling	Target site of action	Response to neuronal activation	Signal or mechanism

Neurovascular	SMC^a of blood vessels	Vasodilation, increased blood flow	Various substances, reviewed in Toda and Okamura (1998), Feuerstein and Miller (1997), Wahl and Schilling (1993)
Neurometabolic	Neurons	Activation of the glycolytic enzymes hexokinase, phosphofructokinase and pyruvate kinase	Decreased cytoplasmic ATP concentration, reviewed in Magistretti (2003)
	Astrocytes	Stimulation of glycolysis	Na/glutamate uptake and activation of Na/K-pump, reviewed in Magistretti and Pellerin (1999)
	Interstitial glucose concentration	Decreased interstitial glucose stimulates glucose transport over the blood-brain barrier	Law of mass action, see text
Neurobarrier	Blood-brain barrier Endothelial cells	Increased blood-brain barrier GLUT-1 Transporter Concentration Or Activity	Not known, see text

^aSmooth muscle cell.

Signals Influencing GLUT-1 Activity or Incorporation

Neurobarrier coupling as demonstrated in the Cornford et al (2000) study probably involves a signal that is released from the neural tissue and acts at the level of blood-brain barrier endothelial cells to trigger changes in GLUT-1 activity or incorporation. Increased GLUT-1 incorporation into the endothelial plasma membranes can be accomplished by increased transporter expression, by increased stability of the GLUT-1 mRNA, or by translocation of the transporter from a preexisting intracellular pool. Blood-brain barrier endothelial cells contain a large intracellular GLUT-1 pool of approximately 40% of the total cellular content, with the other 60% being symmetrically (Simpson et al, 2001) or asymmetrically (luminal to abluminal ratio of approximately 1:4; Dobrogowska and Vorbrodt, 1999; Farrell and Pardridge, 1991) distributed over the luminal and abluminal plasma membranes. GLUT-1 redistribution towards the plasma membrane has previously been suggested as a possible scenario to rapidly increase glucose transport in response to neuronal activation (Drewes, 1998). Modulation of the GLUT-1-mediated transport, either by effects on the intrinsic transporter activity or its incorporation into plasma membranes, can be brought about by numerous and diverse substances including growth factors, mitogens, hormones, neurotransmitters and intracellular messengers and also by pathologic stimuli involving cell stress, metabolic inhibition, hypoxia, and ischemia. Table 3 summarizes the modulatory, mostly stimulating, effect of various of these substances or conditions and specifies the mechanism involved, that is, through alterations in protein expression, mRNA stability, translocation of the transporter, or changes in the intrinsic transporter activity. The most prevalent mechanism is increased expression, which acts at a time scale of hours, but rapid effects occurring within min or even sec have also been reported and are often associated with subsequent changes in expression (Thomson and Gould, 1997).

Table 3

Overview of modulatory influences on the GLUT-1 glucose transporter

Signals	Acute effects ^a	Trans-location ^b	Activity ^c	Expression ^d	mRNA stability ^e	Cell type	Reference

Extracellular signals
Angiotensin-II	30 mins	X		X		Vascular SMC^f	Low et al (1992)
				X		Vascular SMC	Quinn and McCumbee (1998)
	30 mins	X		X	X	Astroglia	Tang et al (1995)
ATP^g		X				Cardiomyocytes	Fischer et al (1999)
Glutamate	10 secs		X (V_max)			Astrocytes	Loaiza et al (2003)
Histamine	5 mins					Cardiac EC^h	Thomas et al (1995)
Brain-derived peptides				X	X	Rat in vivo blood-brain barrier	Boado et al (1999)
Dexamethasone				X		L6 skeletal muscle	Ewart et al (1998)
Insulin				X		Hepatoma cells	Barthel et al (1999)
Thyroid hormone			X	X		Clone 9ⁱ	Shetty et al (1996)
TNF-α	30 mins	X		X	X	Preadipocytes	Cornelius et al (1991)
Intracellular signals
Arachidonic acid			X	X		3T3-L1^j	Fong et al (1999)
PLC pathway	10 mins					Clone 9, 3T3-L1	Prasad et al (1999), Prasad and Ismail-Beigi (1999)
Calcium ions						Clone 9	Quintanilla et al (2000)
	5 mins					L6 skeletal muscle	Khayat et al (1998)
Ca-channel antagonist^g	1 min					PC12 neurons	Ardizzone et al (2002)
Calcium-calmodulin	X					Vascular SMC	Quinn and McCumbee (1998)
cAMP	30 mins	X		X	X	Pre-adipocytes	Cornelius et al (1991)
				X		Choriocarcinoma	Ogura et al (2000)
				X		Skeletal muscle	Vinals et al (1997)
				X		3T3-L1	Fong et al (1999)
Akt kinase				X		Hepatoma cells	Barthel et al (1999)
AMP kinase	10 mins		X (V_max)			Clone 9, 3T3-L1	Abbud et al (2000), Barnes et al (2002)
MAP kinase	30 mins					Clone 9, 3T3-L1	Barros et al (1997b)
PI3 kinase		X				Myoblasts	Kaliman et al (1995)
PKC	2–9 mins	X				Adipocytes	Nishimura and Simpson (1994)
3T3-L1							Bosch et al (2003)
	5 mins					L6 skeletal muscle	Khayat et al (1998)
Tyrosine kinases						Clone 9	Prasad and Ismail-Beigi (1999)
Phosphatase inhibition			X			3T3-L1	Yoo-Warren et al (1993)
Pathological signals
Calcium stress				X	X	Clone 9	Mitani et al (1995), Mitani et al (1996)
				X		Renal epithelial cells	Dominguez et al (1996)
Osmotic stress						Clone 9	Barros et al (1997a)
Oxidative stress	5 mins					Clone 9	Prasad and Ismail-Beigi (1999)
				X		L6 skeletal muscle 3T3-L1	Kozlovsky et al (1997a,b)
Metabolic stress Inhibition of oxidative phosporylation		X	X	X	X	Clone 9	Becker et al (1996), Behrooz and Ismail-Beigi (1998), Hamrahian et al (1999), Shetty et al (1993a, b ), Shi et al (1995)
						L6 skeletal muscle	Khayat et al (1998)
	30 mins					Clone 9, 3T3-L1	Barros et al (1997b)
Hypoxia				X		Clone 9	Behrooz and Ismail-Beigi (1997)
Ischemia				X		Rat brain	Lee and Bondy (1993), Urabe et al (1996)
Hypoxia/ischemia						Rat brain	Vannucci et al (1998b)
Transplantation^g						Reactive astroglia	Rosenstein and More (1994)
Postinjury gliosis						Reactive astroglia	Rosenstein et al (1994)

^aStimulation of the transport within the approximate time period indicated; not specified if more than 30 min.

^bTranslocation: transport stimulation due to translocation from an intracellular pool to the plasma membrane.

^cActivity: stimulation of the intrinsic activity of the GLUT-1 transport protein.

^dExpression: transport stimulation due to increased GLUT-1 expression.

^eIncreased stability of GLUT-1 mRNA due to decreased degradation.

^fSMC: smooth muscle cells.

^gDepresses the transport

^hEC: endothelial cells.

ⁱRat liver epithelial cell line.

^jAdipocyte cell line.

Most relevant in the context of neurobarrier coupling are the rapid effects, at a time scale of sec to min, of angiotensin-II, glutamate, histamine, and of some of the intracellular signals like PLC, cAMP, calcium, and PKC. The role of the PLC pathway has been documented in several reports (Prasad et al, 1999; Prasad and Ismail-Beigi, 1999) with downstream cytoplasmic calcium changes playing a permissive role in GLUT-1 activation (Khayat et al, 1998; Quintanilla et al, 2000) and PKC either stimulating (Khayat et al, 1998; Nishimura and Simpson, 1994; Tang et al, 1995) or inhibiting GLUT-1-mediated glucose transport (Bosch et al, 2003). Previous work of our group has demonstrated astrocyte-to-endothelial cell communication of inositol trisphosphate (InsP₃)-triggered calcium signals and we have put forward the hypothesis that the PLC pathway, at the level of InsP₃, calcium, diacyl glycerol, or PKC, may be an endothelial signal involved in neurobarrier coupling (Braet et al, 2001; Leybaert et al, 1998). On the same lines, Simard et al (2003) have recently speculated on astrocyte-endothelium calcium signal communication as a message influencing metabolic trafficking over the blood-brain barrier.

Calcium changes brought about by calcium influx induced by ionophores are also known to trigger increased GLUT-1 expression, but because the applied exposure times are in the order of hours these effects are likely to be mediated by cellular calcium stress (Dominguez et al, 1996; Mitani et al, 1995). Calcium ionophore exposure also triggers rapid changes (within 2 min) in GLUT-1 mRNA indicating that this response is not solely related to calcium stress (Mitani et al, 1996). The most rapid effect has been reported for glutamate, which in astrocytes triggers an increase of GLUT-1-mediated transport within several sec (Loaiza et al, 2003). Glucose transport was elegantly measured in this study by confocal imaging of the cellular uptake of fluorescent glucose derivatives, allowing the resolution of glucose transport dynamics at a high temporal definition. The specificity of these fluorescent reporters is, however, not fully established and the glutamate concentrations used were in the high range (0.5 mmol/L). The importance of this work is that it suggests that the activity of glutamatergic neurons, and the consequent synaptic spillover of glutamate (Dzubay and Jahr, 1999), may stimulate the activity of glucose transport across the astrocytic plasma membrane, thereby coupling neuronal activity to astrocytic glucose uptake. Coupling at this level is, however, expected to be less important, because there is little evidence for a glucose concentration gradient over the astrocytic (and neuronal) plasma membranes (Gjedde and Diemer, 1983; Gruetter et al, 1996; Pfeuffer et al, 2000; Silver and Erecinska, 1994). It remains to be determined whether glutamate also affects glucose transporter activity at the level of blood-brain barrier endothelial cells. Blood-brain barrier endothelial cells appear to express glutamate receptors but there is some controversy about whether these receptors couple to functional responses (Krizbai et al, 1998; Morley et al, 1998; Parfenova et al, 2003). Next to glutamate, other transmitter substances with somewhat slower effects on glucose transport should also be considered. Histamine, acting with a time scale of min, is in principle too slow to accommodate an instantaneous change in glucose flux. A delayed elevation of the glucose transport over several min may however be useful to back up depleted astrocytic glycogen stores after their mobilization in response to increased metabolic demands (Swanson, 1992; Swanson et al, 1992; Gruetter, 2003). This is an especially interesting possibility because monoamine messengers like histamine, noradrenaline, and serotonin are known to have glycogenolytic actions in the brain (Fillenz et al, 1999; Magistretti, 2003; Magistretti et al, 1993; Medrano et al, 1992). Preliminary work from our group indicates that histamine stimulates the uptake of glucose into endothelial cells. In addition to histamine, ATP also appeared to stimulate endothelial glucose uptake (Braet and Leybaert, 2000a, b ). However, Simard et al (2003) have recently reported that there is no immunocytochemical evidence for P₂Y₂ and P₂Y₄ ATP receptors in endothelia of acutely isolated rat brain slices, making ATP a less likely candidate messenger. Further studies focusing on the effect of various candidate extra- and intra cellular messengers on endothelial glucose uptake and transendothelial transport at a second-to-minute time scale will be needed to determine the role of various other candidate signaling molecules. In situ confocal and multiphoton imaging should be the standard procedure for such investigations to come to valid and realistic conclusions. Finally, it should be taken into account that only small changes in transport activity will be needed to prevent blood-brain barrier glucose transport from becoming rate-limiting on neuronal activation.

Concluding Remarks

In conclusion, glucose transport across the blood-brain barrier is not rate-limiting under basal conditions but is expected to become so after activation. Glucose transport thus needs to be increased on activation, an increase that can be brought about by increased blood flow and consequent functional (capillary) recruitment (through neurovascular coupling), by an increased driving force for facilitated glucose transport (a consequence of increased glucose consumption brought about by neurometabolic coupling), and possibly also by changes in the transport parameters of blood-brain barrier glucose transport (through neurobarrier coupling). Arguments for a coupling effect at the level of the blood-brain barrier are based on experimentally observed rapid changes in the Michaelis-Menten parameters of glucose transport in response to seizure induction, on the fact that a large variety of intra- and extracellular messengers modulate GLUT-1-mediated transport, and on the notion that astrocyte-to-endothelial cell communication may constitute the pathway through which neuronal activity exerts its effects on the blood-brain barrier. We presented the case for neurobarrier coupling based on glucose transport and metabolism. The barrier, however, controls the passage of many other substances including monocarboxylic acid fuels (lactate, acetate, pyruvate, ketone bodies), precursors of amine neurotransmitters, ions (sodium, potassum, chloride) and water, all of which can be speculated to be adapted in function of neuronal activity. Further work will be needed to document the case for neurobarrier coupling in the in vivo setting and to delineate candidate messengers in in vitro assays and experiments, so as to establish whether it is really a partner of neurovascular and neurometabolic coupling. Looking from two different angles to the neurovascular unit, with molecular imaging at the microscopic level and functional magnetic resonance imaging to look at the greater picture will hopefully bring us a step closer.

Footnotes

Acknowledgements

This manuscript is dedicated to I Leusen, Professor Emeritus of Physiology at Ghent University and to G Dupont, Professor at the Université Libre de Bruxelles, in an effort to describe some recently suggested modeling ideas in a more precise manner.

1

This ratio should not to be confused with T_max/CMR_G, which attains higher values in the order of 3 (Choi et al, 2001; de Graaf et al, 2001).

2

Permeability is used in this context in a rather broad sense and not in its strict meaning of membrane property equaling the diffusion constant divided by the membrane thickness. Permeability does not appear as such in the Michaelis-Menten equation but the diffusion constant is part of a term expressing V_max or T_max.

References

Abbud

Habinowski

Zhang

Kendrew

Elkairi

Kemp

Witters

Ismail-Beigi

(2000) Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport. Arch Biochem Biophys 380:347–52

Akgoren

Lauritzen

(1999) Functional recruitment of red blood cells to rat brain microcirculation accompanying increased neuronal activity in cerebellar cortex. Neuroreport 10:3257–63

Ardizzone

Dwyer

(2002) Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists. Am J Physiol Cell Physiol 283:C579–586

Attwell

Iadecola

(2002) The neural basis of functional brain imaging signals. Trends Neurosci 25:621–5

Aubert

Costalat

(2002) A model of the coupling between brain electrical activity, metabolism, and hemodynamics: application to the interpretation of functional neuroimaging. Neuroimage 17:1162–81

Barinaga

(1997) What makes brain neurons run? Science 276:196–8

Barnes

Ingram

Porras

Barros

Hudson

Fryer

Foufelle

Carling

Hardie

Baldwin

(2002) Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J Cell Sci 115:2433–42

Barros

Baldwin

Griffiths

(1997a) Rapid activation of GLUT1 by osmotic stress. Biochem Soc Trans 25:485S

Barros

Young

Saklatvala

Baldwin

(1997b) Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells. J Physiol 504(Part 3):517–25

10.

Barthel

Okino

Liao

Nakatani

Whitlock

Jr Roth

(1999) Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem 274:20281–6

11.

Bauer

Sonnleitner

Lametschwandtner

Steiner

Adam

Bauer

(1995) Ontogenic expression of the erythroid-type glucose transporter (Glut 1) in the telencephalon of the mouse: correlation to the tightening of the blood-brain barrier. Brain Res Dev Brain Res 86:317–25

12.

Becker

Newman

Ismail-Beigi

(1996) Stimulation of GLUT1 glucose transporter expression in response to inhibition of oxidative phosphorylation: role of reduced sulfhydryl groups. Mol Cell Endocrinol 121: 165–170

13.

Behrooz

Ismail-Beigi

(1997) Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation. J Biol Chem 272:5555–62

14.

Behrooz

Ismail-Beigi

(1998) Induction of GLUT1 mRNA in response to azide and inhibition of protein synthesis. Mol Cell Biochem 187:33–40

15.

Betz

Iannotti

(1983) Simultaneous determination of regional cerebral blood flow and blood-brain glucose transport kinetics in the gerbil. J Cereb Blood Flow Metab 3:193–9

16.

Bittar

Charnay

Pellerin

Bouras

Magistretti

(1996) Selective distribution of lactate dehydrogenase isoenzymes in neurons and astrocytes of human brain. J Cereb Blood Flow Metab 16:1079–89

17.

Blomqvist

Grill

Ingvar

Widen

Stone-Elander

(1998) The effect of hyperglycaemia on regional cerebral glucose oxidation in humans studied with [1–11C]-d-glucose. Acta Physiol Scand 163:403–15

18.

Boado

Windisch

(1999) In vivo upregulation of the blood-brain barrier GLUT1 glucose transporter by brain-derived peptides. Neurosci Res 34:217–24

19.

Bosch

Bazuine

Wake

Span

Olthaar

Schurmann

Maassen

Hermus

Willems

Sweep

(2003) Inhibition of protein kinase CbetaII increases glucose uptake in 3T3-L1 adipocytes through elevated expression of glucose transporter 1 at the plasma membrane. Mol Endocrinol 17:1230–9

20.

Braet

Leybaert

(2000a) Acute stimulation of glucose transport in endothelial cells by ATP and histamine. Eur J Neurosci 12(suppl S2000):356

21.

Braet

Leybaert

(2000b) Endothelial GLUT-1-mediated glucose uptake is acutely stimulated by ATP and histamine. Eur J Physiology 440:R6

22.

Braet

Paemeleire

D'Herde

Sanderson

Leybaert

(2001) Astrocyte-endothelial cell calcium signals conveyed by two signalling pathways. Eur J Neurosci 13:79–91

23.

Brown

Baltan Tekkok

Ransom

(2004) Energy transfer from astrocytes to axons: the role of CNS glycogen. Neurochem Int 45:529–36

24.

Bryan

Jr Hawkins

Mans

Davis

Page

(1983) Cerebral glucose utilization in awake unstressed rats. Am J Physiol 244:C270–275

25.

Buxton

Frank

(1997) A model for the coupling between cerebral blood flow and oxygen metabolism during neural stimulation. J Cereb Blood Flow Metab 17:64–72

26.

Carruthers

(1990) Facilitated diffusion of glucose. Physiol Rev 70:1135–76

27.

Chen

Novotny

Zhu

Rothman

Shulman

(1993) Localized 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci USA 90:9896–900

28.

Chih

Roberts

Jr (2003) Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis. J Cereb Blood Flow Metab 23:1263–81

29.

Choi

Lee

Kim

Gruetter

(2001) In vivo measurements of brain glucose transport using the reversible Michaelis-Menten model and simultaneous measurements of cerebral blood flow changes during hypoglycemia. J Cereb Blood Flow Metab 21:653–63

30.

Christensen

Diemer

Laursen

Gjedde

(1981) Starvation accelerates blood-brain glucose transfer. Acta Physiol Scand 112:221–3

31.

Clarke

Sokoloff

(1999) Circulation and energy metabolism of the brain. In: Basic neurochemistry ( Siegel

Agranoff

Albers

, eds), Philadelphia: Lippincott-Raven, 637–69

32.

Cornelius

Marlowe

Call

Pekala

(1991) Regulation of glucose transport as well as glucose transporter and immediate early gene expression in 3T3-L1 preadipocytes by 8-bromo-cAMP. J Cell Physiol 146:298–308

33.

Cornford

Nguyen

Landaw

(2000) Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am J Physiol Heart Circ Physiol 279:H1346–1354

34.

Cremer

Cunningham

Seville

(1983) Relationships between extraction and metabolism of glucose, blood flow, and tissue blood volume in regions of rat brain. J Cereb Blood Flow Metab 3:291–302

35.

Cunningham

(1986) The influence of transport and metabolism on brain glucose content. Ann NY Acad Sci 481:161–73

36.

Cunningham

Hargreaves

Pelling

Moorhouse

(1986) Regional blood-brain glucose transfer in the rat: a novel double-membrane kinetic analysis. J Cereb Blood Flow Metab 6:305–14

37.

Davson

Segal

(1996) Physiology of the CSF and blood-brain barriers. Boca Raton, FL: CRC Press

38.

de Graaf

Pan

Telang

Lee

Brown

Novotny

Hetherington

Rothman

(2001) Differentiation of glucose transport in human brain gray and white matter. J Cereb Blood Flow Metab 21:483–92

39.

De Vivo

Trifiletti

Jacobson

Ronen

Behmand

Harik

(1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325:703–9

40.

Deitmer

(2001) Strategies for metabolic exchange between glial cells and neurons. Respir Physiol 129:71–81

41.

Devaskar

Zahm

Holtzclaw

Chundu

Wadzinski

(1991) Developmental regulation of the distribution of rat brain insulin-insensitive (Glut 1) glucose transporter. Endocrinology 129:1530–40

42.

Dirnagl

(1997) Metabolic aspects of neurovascular coupling. Adv Exp Med Biol 413:155–9

43.

Dobrogowska

Vorbrodt

(1999) Quantitative immunocytochemical study of blood-brain barrier glucose transporter (GLUT-1) in four regions of mouse brain. J Histochem Cytochem 47:1021–30

44.

Dominguez

Song

Liu-Chen

Qulali

Howard

Lee

McAteer

(1996) Studies of renal injury. II. Activation of the glucose transporter 1 (GLUT1) gene and glycolysis in LLC-PK1 cells under Ca²⁺ stress. J Clin Invest 98:395–404

45.

Drewes

(1998) Biology of the blood-brain barrier glucose transporter. In: Introduction to the blood-brain barrier-methodology, biology and pathology ( Pardridge

, ed), Cambridge: Cambridge University Press, 165–74

46.

Dwyer

Vannucci

Simpson

(2002) Expression, regulation, and functional role of glucose transporters (GLUTs) in brain. Int Rev Neurobiol 51:159–88

47.

Dzubay

Jahr

(1999) The concentration of synaptically released glutamate outside of the climbing fiber-Purkinje cell synaptic cleft. J Neurosci 19:5265–74

48.

Ewart

Somwar

Klip

(1998) Dexamethasone stimulates the expression of GLUT1 and GLUT4 proteins via different signalling pathways in L6 skeletal muscle cells. FEBS Lett 425:179–83

49.

Farrell

Pardridge

(1991) Blood-brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study. Proc Natl Acad Sci USA 88:5779–83

50.

Fellows

Boutelle

Fillenz

(1992) Extracellular brain glucose levels reflect local neuronal activity: a microdialysis study in awake, freely moving rats. J Neurochem 59:2141–7

51.

Feuerstein

Miller

(1997) Vasoactive mediators of cerebral vessels. In: Primer on cerebrovascular diseases ( Welch

KMA

Caplan

Reis

, eds), San Diego: Academic Press

52.

Fillenz

Lowry

Boutelle

Fray

(1999) The role of astrocytes and noradrenaline in neuronal glucose metabolism. Acta Physiol Scand 167:275–84

53.

Fischer

Becker

Loken

(1999) Purinergic inhibition of glucose transport in cardiomyocytes. J Biol Chem 274:755–61

54.

Fong

Chen

Liu

Chai

Kao

(1999) Synergistic effect of arachidonic acid and cyclic AMP on glucose transport in 3T3-L1 adipocytes. Cell Signal 11:53–8

55.

Fox

Raichle

Mintun

Dence

(1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241:462–4

56.

Fray

Boutelle

Fillenz

(1997) Extracellular glucose turnover in the striatum of unanaesthetized rats measured by quantitative microdialysis. J Physiol 504(Part 3):721–6

57.

Friedman

(1986) Principles and modes of biological transport. Berlin, Heidelberg: Springer-Verlag

58.

Furler

Jenkins

Storlien

Kraegen

(1991) In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats. Am J Physiol 261: E337–EE347

59.

Ginsberg

Smith

Wachtel

Gonzalez-Carvajal

Busto

(1986) Simultaneous determination of local cerebral glucose utilization and blood flow by carbon-14 double-label autoradiography: method of procedure and validation studies in the rat. J Cereb Blood Flow Metab 6:273–85

60.

Gjedde

(1992) Blood-brain glucose transfer. In: Physiology and pharmacology of the blood-brain barrier ( Bradbury

, ed), New York: Springer-Verlag, 65–117

61.

Gjedde

Crone

(1981) Blood-brain glucose transfer: repression in chronic hyperglycemia. Science 214:456–7

62.

Gjedde

Diemer

(1983) Autoradiographic determination of regional brain glucose content. J Cereb Blood Flow Metab 3:303–10

63.

Gjedde

Diemer

(1985) Double-tracer study of the fine regional blood-brain glucose transfer in the rat by computer-assisted autoradiography. J Cereb Blood Flow Metab 5:282–9

64.

Gobel

Klein

Schrock

Kuschinsky

(1989) Lack of capillary recruitment in the brains of awake rats during hypercapnia. J Cereb Blood Flow Metab 9:491–9

65.

Gronlund

Gerhart

Leino

McCall

Drewes

(1996) Chronic seizures increase glucose transporter abundance in rat brain. J Neuropathol Exp Neurol 55:832–40

66.

Gruetter

(2003) Glycogen: the forgotten cerebral energy store. J Neurosci Res 74:179–83

67.

Gruetter

Novotny

Boulware

Rothman

Mason

Shulman

Tamborlane

(1992) Direct measurement of brain glucose concentrations in humans by 13C NMR spectroscopy. Proc Natl Acad Sci USA 89:1109–12

68.

Gruetter

Novotny

Boulware

Rothman

Shulman

(1996) 1H NMR studies of glucose transport in the human brain. J Cereb Blood Flow Metab 16:427–38

69.

Gruetter

Ugurbil

Seaquist

(1998) Steady-state cerebral glucose concentrations and transport in the human brain. J Neurochem 70:397–408

70.

Hamrahian

Zhang

Elkhairi

Prasad

Ismail-Beigi

(1999) Activation of Glut1 glucose transporter in response to inhibition of oxidative phosphorylation. Arch Biochem Biophys 368:375–9

71.

Harder

Alkayed

Lange

Gebremedhin

Roman

(1998) Functional hyperemia in the brain: hypothesis for astrocyte-derived vasodilator metabolites. Stroke 29:229–34

72.

Hasselbalch

Holm

Pedersen

Svarer

Knudsen

Madsen

Paulson

(2001a) The (18)F-fluorodeoxyglucose lumped constant determined in human brain from extraction fractions of (18)F-fluorodeoxyglucose and glucose. J Cereb Blood Flow Metab 21:995–1002

73.

Hasselbalch

Knudsen

Capaldo

Postiglione

Paulson

(2001b) Blood-brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab 86: 1986–1990

74.

Hasselbalch

Knudsen

Jakobsen

Hageman

Holm

Paulson

(1995) Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 268: E1161–EE1166

75.

Hawkins

Mans

Davis

Hibbard

(1983) Glucose availability to individual cerebral structures is correlated to glucose metabolism. J Neurochem 40:1013–8

76.

Hawkins

Mans

Davis

Vina

Hibbard

(1985) Cerebral glucose use measured with [14C]glucose labeled in the 1, 2, or 6 position. Am J Physiol 248: C170–CC176

77.

Hertz

Kala

Schousboe

(2000) Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem Int 37:83–102

78.

Wilson

(1997) Rapid changes in local extracellular rat brain glucose observed with an in vivo glucose sensor. J Neurochem 68:1745–52

79.

Hyder

Chase

Behar

Mason

Siddeek

Rothman

Shulman

(1996) Increased tricarboxylic acid cycle flux in rat brain during forepaw stimulation detected with 1H[13C]NMR. Proc Natl Acad Sci USA 93:7612–7

80.

Iadecola

(1993) Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link? Trends Neurosci 16:206–14

81.

Kalaria

Harik

(1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 53:1083–8

82.

Kaliman

Vinals

Testar

Palacin

Zorzano

(1995) Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J 312(Part 2): 471–7

83.

Kasischke

Vishwasrao

Fisher

Zipfel

Webb

(2004) Neural activity triggers neuronal oxidative metabolism followed by astrocytic glycolysis. Science 305:99–103

84.

Khayat

Tsakiridis

Ueyama

Somwar

Ebina

Klip

(1998) Rapid stimulation of glucose transport by mitochondrial uncoupling depends in part on cytosolic Ca²⁺ and cPKC. Am J Physiol 275:C1487–C97

85.

Kleinfeld

Mitra

Helmchen

Denk

(1998) Fluctuations and stimulus-induced changes in blood flow observed in individual capillaries in layers 2 through 4 of rat neocortex. Proc Natl Acad Sci USA 95: 15741–15746

86.

Klepper

Wang

Fischbarg

Vera

Jarjour

O'Driscoll

De Vivo

(1999) Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome. Neurochem Res 24: 587–594

87.

Kozlovsky

Rudich

Potashnik

Bashan

(1997a) Reactive oxygen species activate glucose transport in L6 myotubes. Free Radic Biol Med 23:859–69

88.

Kozlovsky

Rudich

Potashnik

Ebina

Murakami

Bashan

(1997b) Transcriptional activation of the Glut1 gene in response to oxidative stress in L6 myotubes. J Biol Chem 272:33367–72

89.

Krizbai

Deli

Pestenacz

Siklos

Szabo

Andras

Joo

(1998) Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res 54:814–9

90.

Kuschinsky

(1997) Neuronal-vascular coupling. A unifying hypothesis. Adv Exp Med Biol 413:167–76

91.

Kuschinsky

Paulson

(1992) Capillary circulation in the brain. Cerebrovasc Brain Metab Rev 4:261–86

92.

Lee

Bondy

(1993) Ischemic injury induces brain glucose transporter gene expression. Endocrinology 133:2540–4

93.

Leino

Gerhart

van Bueren

McCall

Drewes

(1997) Ultrastructural localization of GLUT 1 and GLUT 3 glucose transporters in rat brain. J Neurosci Res 49:617–26

94.

Leybaert

Paemeleire

Strahonja

Sanderson

(1998) Inositol-trisphosphate-dependent intercellular calcium signaling in and between astrocytes and endothelial cells. Glia 24:398–407

95.

Loaiza

Porras

Barros

(2003) Glutamate triggers rapid glucose transport stimulation in astrocytes as evidenced by real-time confocal microscopy. J Neurosci 23:7337–42

96.

Lou

Edvinsson

MacKenzie

(1987) The concept of coupling blood flow to brain function: revision required? Ann Neurol 22:289–97

97.

Low

Ross

Grigor

(1992) Angiotensin II stimulates glucose transport activity in cultured vascular smooth muscle cells. J Biol Chem 267:20740–5

98.

Lowry

O'Neill

Boutelle

Fillenz

(1998) Continuous monitoring of extracellular glucose concentrations in the striatum of freely moving rats with an implanted glucose biosensor. J Neurochem 70: 391–396

99.

Lund-Andersen

(1979) Transport of glucose from blood to brain. Physiol Rev 59:305–52

100.

Madsen

Hasselbalch

Hagemann

Olsen

Bulow

Holm

Wildschiodtz

Paulson

Lassen

(1995) Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 15:485–91

101.

Magistretti

(2003) Brain energy metabolism. In: Fundamental neuroscience ( Squire

Bloom

McConnell

, eds), San Diego: Academic Press, 339–60

102.

Magistretti

Pellerin

(1999) Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B Biol Sci 354:1155–63

103.

Magistretti

Pellerin

Rothman

Shulman

(1999) Energy on demand. Science 283:496–7

104.

Magistretti

Sorg

Martin

Pellerin

(1993) Neurotransmitters regulate energy metabolism in astrocytes: implications for the metabolic trafficking between neural cells. Dev Neurosci 15:306–12

105.

Malonek

Dirnagl

Lindauer

Yamada

Kanno

Grinvald

(1997) Vascular imprints of neuronal activity: relationships between the dynamics of cortical blood flow, oxygenation, and volume changes following sensory stimulation. Proc Natl Acad Sci USA 94:14826–31

106.

Mason

Behar

Rothman

Shulman

(1992) NMR determination of intracerebral glucose concentration and transport kinetics in rat brain. J Cereb Blood Flow Metab 12:448–55

107.

McCall

Millington

Wurtman

(1982) Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci USA 79:5406–10

108.

McNay

Fries

Gold

(2000) Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc Natl Acad Sci USA 97:2881–5

109.

McNay

Gold

(1999) Extracellular glucose concentrations in the rat hippocampus measured by zero-net-flux: effects of microdialysis flow rate, strain, and age. J Neurochem 72:785–90

110.

McNay

McCarty

Gold

(2001) Fluctuations in brain glucose concentration during behavioral testing: dissociations between brain areas and between brain and blood. Neurobiol Learn Mem 75:325–37

111.

Medrano

Gruenstein

Dimlich

(1992) Histamine stimulates glycogenolysis in human astrocytoma cells by increasing intracellular free calcium. Brain Res 592:202–7

112.

Merboldt

Bruhn

Hanicke

Michaelis

Frahm

(1992) Decrease of glucose in the human visual cortex during photic stimulation. Magn Reson Med 25:187–94

113.

Mintun

Lundstrom

Snyder

Vlassenko

Shulman

Raichle

(2001) Blood flow and oxygen delivery to human brain during functional activity: theoretical modeling and experimental data. Proc Natl Acad Sci USA 98:6859–64

114.

Mitani

Behrooz

Dubyak

Ismail-Beigi

(1995) Stimulation of GLUT-1 glucose transporter expression in response to exposure to calcium ionophore A-23187. Am J Physiol 269:C1228–C34

115.

Mitani

Dubyak

Ismail-Beigi

(1996) Induction of GLUT-1 mRNA in response to inhibition of oxidative phosphorylation: role of increased [Ca²⁺]i. Am J Physiol 270:C235–C42

116.

Mooradian

Morin

(1991) Brain uptake of glucose in diabetes mellitus: the role of glucose transporters. Am J Med Sci 301:173–7

117.

Morley

Small

Murray

Mealing

Poulter

Durkin

Stanimirovic

(1998) Evidence that functional glutamate receptors are not expressed on rat or human cerebromicrovascular endothelial cells. J Cereb Blood Flow Metab 18:396–406

118.

Nishimura

Simpson

(1994) Staurosporine inhibits phorbol 12-myristate 13-acetate- and insulin-stimulated translocation of GLUT1 and GLUT4 glucose transporters in rat adipose cells. Biochem J 302(Part 1): 271–7

119.

Ogura

Sakata

Okamoto

Yasui

Tadokoro

Yoshimoto

Yamaguchi

Kurachi

Maeda

Murata

(2000) 8-Bromo-cyclicAMP stimulates glucose transporter-1 expression in a human choriocarcinoma cell line. J Endocrinol 164:171–8

120.

Pardridge

(1983) Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 63: 1481–1535

121.

Pardridge

(1991) Advances in cell biology of blood-brain barrier transport. Semin Cell Biol 2:419–26

122.

Pardridge

Triguero

Farrell

(1990) Down-regulation of blood-brain barrier glucose transporter in experimental diabetes. Diabetes 39:1040–4

123.

Parfenova

Fedinec

Leffler

(2003) Ionotropic glutamate receptors in cerebral microvascular endothelium are functionally linked to heme oxygenase. J Cereb Blood Flow Metab 23:190–7

124.

Paulson

(2002) Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol 12:495–501

125.

Pellerin

Magistretti

(1997) Glutamate uptake stimulates Na⁺,K⁺-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain. J Neurochem 69:2132–7

126.

Pellerin

Pellegri

Bittar

Charnay

Bouras

Martin

Stella

Magistretti

(1998) Evidence supporting the existence of an activity-dependent astrocyte-neuron lactate shuttle. Dev Neurosci 20: 291–299

127.

Pelligrino

Segil

Albrecht

(1990) Brain glucose utilization and transport and cortical function in chronic vs. acute hypoglycemia. Am J Physiol 259: E729–EE735

128.

Pfeuffer

Tkac

Gruetter

(2000) Extracellular-intracellular distribution of glucose and lactate in the rat brain assessed noninvasively by diffusion-weighted 1H nuclear magnetic resonance spectroscopy in vivo. J Cereb Blood Flow Metab 20:736–46

129.

Prasad

Behrooz

Ismail-Beigi

(1999) LY-83583 stimulates glucose transporter-1-mediated glucose transport independent of changes in cGMP levels. Eur J Pharmacol 366:101–9

130.

Prasad

Ismail-Beigi

(1999) Mechanism of stimulation of glucose transport by H₂O₂: role of phospholipase C. Arch Biochem Biophys 362:113–22

131.

Quinn

McCumbee

(1998) Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 177: 94–102

132.

Quintanilla

Porras

Castro

Barros

(2000) Cytosolic [Ca(2+)] modulates basal GLUT1 activity and plays a permissive role in its activation by metabolic stress and insulin in rat epithelial cells. Cell Calcium 28:97–106

133.

Robinson

Rapoport

(1986) Glucose transport and metabolism in the brain. Am J Physiol 250:R127–R36

134.

Rosenstein

(1994) Immunocytochemical expression of the blood-brain barrier glucose transporter (GLUT-1) in neural transplants and brain wounds. J Comp Neurol 350:229–40

135.

Rosenstein

Krum

(1994) Immunocytochemical distribution of the brain glucose transporter (GLUT 1) in experimental gliosis. Brain Res 659:277–82

136.

Rothman

(2001) Studies of metabolic compartmentation and glucose transport using in vivo MRS. NMR Biomed 14:149–60

137.

Schrock

Kuschinsky

(1988) Cerebral blood flow, glucose use, and CSF ionic regulation in potassium-depleted rats. Am J Physiol 254:H250–H7

138.

Schurr

Miller

Payne

Rigor

(1999) An increase in lactate output by brain tissue serves to meet the energy needs of glutamate-activated neurons. J Neurosci 19:34–9

139.

Shetty

Ismail-Beigi

Loeb

Ismail-Beigi

(1993a) Induction of GLUT1 mRNA in response to inhibition of oxidative phosphorylation. Am J Physiol 265:C1224–C9

140.

Shetty

Kuruvilla

Ismail-Beigi

Loeb

(1996) Stimulation of glucose transport in Clone 9 cells by insulin and thyroid hormone: role of GLUT-1 activation. Biochim Biophys Acta 1314:140–6

141.

Shetty

Loeb

Vikstrom

Ismail-Beigi

(1993b) Rapid activation of GLUT-1 glucose transporter following inhibition of oxidative phosphorylation in clone 9 cells. J Biol Chem 268:17225–32

142.

Shi

Liu

Vanderburg

Samuel

Ismail-Beigi

Jung

(1995) Modulation of GLUT1 intrinsic activity in clone 9 cells by inhibition of oxidative phosphorylation. J Biol Chem 270:21772–8

143.

Shulman

Rothman

(1998) Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc Natl Acad Sci USA 95:11993–8

144.

Shulman

Hyder

Rothman

(2001) Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc Natl Acad Sci USA 98:6417–22

145.

Siesjo

(1978) Brain energy metabolism. New York: John Wiley & Sons Ltd.

146.

Silver

Erecinska

(1994) Extracellular glucose concentration in mammalian brain: continuous monitoring of changes during increased neuronal activity and upon limitation in oxygen supply in normo-, hypo, and hyperglycemic animals. J Neurosci 14:5068–76

147.

Simard

Arcuino

Takano

Liu

Nedergaard

(2003) Signaling at the gliovascular interface. J Neurosci 23:9254–62

148.

Simpson

Vannucci

DeJoseph

Hawkins

(2001) Glucose transporter asymmetries in the bovine blood-brain barrier. J Biol Chem 276:12725–9

149.

Sokoloff

(1977) Relation between physiological function and energy metabolism in the central nervous system. J Neurochem 29:13–26

150.

Sokoloff

(1978) Local cerebral energy metabolism: its relationship to local functional activity and blood flow. In: Cerebral vascular smooth muscle and its control (Ciba Foundation Symposium 56) ( Purves

Elliott

, eds), Amsterdam: Elsevier/Excerpta Medica/North Holland, 171–97

151.

Swanson

(1992) Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol Pharmacol 70(Suppl):S138–S44

152.

Swanson

Morton

Sagar

Sharp

(1992) Sensory stimulation induces local cerebral glycogenolysis: demonstration by autoradiography. Neuroscience 51:451–61

153.

Tang

Richards

Raizada

Sumners

(1995) Angiotensin II increases glucose uptake and glucose transporter-1 mRNA levels in astroglia. Am J Physiol 268:E384–E90

154.

Thomas

Linssen

van der Vusse

Hirsch

Rosen

Kammermeier

Fischer

(1995) Acute stimulation of glucose transport by histamine in cardiac microvascular endothelial cells. Biochim Biophys Acta 1268: 88–96

155.

Thomson

Gould

(1997) Regulation of glucose transport by growth factors and oncogenes. In: Facilitative glucose transporters ( Gould

, ed), Austin, TX: R.G. Landes Company, 197–217

156.

Toda

Okamura

(1998) Cerebral vasodilators. Jpn J Pharmacol 76:349–67

157.

Tsacopoulos

Magistretti

(1996) Metabolic coupling between glia and neurons. J Neurosci 16:877–85

158.

Ueki

Linn

Hossmann

(1988) Functional activation of cerebral blood flow and metabolism before and after global ischemia of rat brain. J Cereb Blood Flow Metab 8:486–94

159.

Urabe

Hattori

Nagamatsu

Sawa

Mizuno

(1996) Expression of glucose transporters in rat brain following transient focal ischemic injury. J Neurochem 67:265–71

160.

Vafaee

Gjedde

(2000) Model of blood-brain transfer of oxygen explains nonlinear flow-metabolism coupling during stimulation of visual cortex. J Cereb Blood Flow Metab 20:747–54

161.

Vannucci

Clark

Koehler-Stec

Smith

Davies

Maher

Simpson

(1998a) Glucose transporter expression in brain: relationship to cerebral glucose utilization. Dev Neurosci 20:369–79

162.

Vannucci

Maher

Simpson

(1997) Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21:2–21

163.

Vannucci

Reinhart

Maher

Bondy

Lee

Vannucci

Simpson

(1998b) Alterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia-ischemia in the immature rat brain. Brain Res Dev Brain Res 107: 255–264

164.

Villringer

Dirnagl

(1995) Coupling of brain activity and cerebral blood flow: basis of functional neuroimaging. Cerebrovasc Brain Metab Rev 7:240–76

165.

Villringer

Them

Lindauer

Einhaupl

Dirnagl

(1994) Capillary perfusion of the rat brain cortex. An in vivo confocal microscopy study. Circ Res 75: 55–62

166.

Vinals

Ferre

Fandos

Santalucia

Testar

Palacin

Zorzano

(1997) Cyclic adenosine 3′,5′-monophosphate regulates GLUT4 and GLUT1 glucose transporter expression and stimulates transcriptional activity of the GLUT1 promoter in muscle cells. Endocrinology 138:2521–9

167.

Vogel

Kuschinsky

(1996) Decreased heterogeneity of capillary plasma flow in the rat whisker-barrel cortex during functional hyperemia. J Cereb Blood Flow Metab 16:1300–6

168.

Wahl

Schilling

(1993) Regulation of cerebral blood flow—a brief review. Acta Neurochir Suppl (Wien) 59: 3–10

169.

Yoo-Warren

Kristie

Karmann

(1993) Okadaic acid increases glucose uptake in 3T3-L1 adipocytes by stimulating glucose transporter 1 expression. Biochem Biophys Res Commun 195:310–6

170.

Zonta

Angulo

Gobbo

Rosengarten

Hossmann

Pozzan

Carmignoto

(2003) Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation. Nat Neurosci 6:43–50

Neurobarrier Coupling in the Brain: A Partner of Neurovascular and Neurometabolic Coupling?

Abstract

Keywords

Introduction

Blood-Brain Barrier Glucose Transport

Adaptation and Regulation of Blood-Brain Barrier Glucose Transport

Glucose Transport and Consumption

Glucose Transport and Neurovascular Coupling

Defining the Field for Neurobarrier Coupling

Signals Influencing GLUT-1 Activity or Incorporation

Concluding Remarks

Footnotes

Acknowledgements

1

2

References